References
- 1. International Agency for Research on Cancer, World Health Organisation, International Association of Cancer Registries. Nasopharyngeal carcinoma. In: Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al, editors. Cancer in five continents, vol IX. IARC Scientific Publication No. 160. Lyon: IARC; 2007.
- 2. Nasopharyngeal carcinoma. In: Khuhaprema T, Srivatanakul P, Attsara A, Sriplung H, Wiangnon H, Sumitsawan Y, editors. Cancer in Thailand. Bangkok: Ministry of health; 2010. p. 16-17.
- 3. Baujet B, Audry H, Bourhis J, Chan AT, Onat H, Chua DT, et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Pys 2006; 64: 47-56.
- 4. Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharygeal cancer: Phase III randomized Intergroup study 0099. J Clin Oncol 1998; 16: 1310-7.
- 5. Chan AT, Leung SF, Ngan RK, Teo PM, Lau WH, Kwan WH, et al. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 2005; 97: 536-9.
- 6. Douple EB, Richmond RC, O’Hara JA, Coughlin CT. Carboplatin as a potentiator of radiation therapy. Cancer Treat Rev 1985; 12(Suppl A): 111-24.
- 7. Coughlin CT, Richmond RC. Biologic and clinical developments of cisplatin combined with radiation: Concepts, utility, projections for new trials, and the emergence of carboplatin. Semin Oncol 1989; 16: 31-43.
- 8. Calais G1, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999; 91: 2081-6.
- 9. Calais G, Le Floch O. Concomitant radiotherapy and chemotherapy in the treatment of cancer of the upper respiratory and digestive tracts. Bull Cancer Radiother 1996; 83: 321-9
- 10. Muggia FM. Overview of carboplatin: Replacing complementing and extending the therapeutic horizons of cisplatin. Semin Oncol 1989; 16(Suppl 5): 7-13.
- 11. Paliament M, Jha N, Rapp E, Smith C, MacKinnon J, Nabholtz JM, et al. Concurrent weekly carboplatin and radiotherapy for nasopharyngeal carcinoma: report of a joint phase II study. Radiother Oncol 2001; 58: 131-6.
- 12. Okita J, Hatta C, Terada T, Saeki N, Ogasawara H, Kakibuchi M, et al. Concurrent chemo-radiotherapy for nasopharyngeal carcinoma. Auris Nasus Larynx 2004; 31: 43-7.
- 13. Chitapanarux I, Lorvidhaya V, Kamnerdsupaphon P, Sumitsawan Y, Tharavichitkul E, Sukthomya V, et al. Chemoradiation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: Randomised, non-inferiority, open trial. Euro J of Cancer 2007; 43: 1399-406.
- 14. Dechaphunkul T, Pruegsanusak K, Sangthawan D, Sanpaeravong P. Concurrent chemoradiotherapy with carboplatin followed by carboplatin and 5- fluorouracil in locally advanced nasopharyngeal carcinoma. Head Neck Oncol 2011; 3: 30.
- 15. Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH, et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int Radiat Oncol Biol Phys 2006; 66: 981-91.
- 16. Kam MK, Leung SF, Zee B, Chau RM, Suen JJ, Mo F, et al. Prospective randomized study of intensity- modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 2007; 25: 4873-9.
- 17. Peng G, Wang T, Yank KY, Zhang S, Zhang T, Li Q, et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol 2012; 104: 286-93.
- 18. Chan J, Bray F, McCarron P, Foo W, Lee AWM, Yip T, et al. Nasopharyngeal carcinoma. In: Barnes EL, Eveson JW, Reichart P, Sidransky D, editors. Pathology and genetics of head and neck tumor. World Health Organization classification of tumours. Lyon: IARC Press; 2005. p. 85.
- 19. Langendijk JA, Leemans CR, Buter J, Berkhof J, Slotman BJ. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol 2004; 22: 4604-12.
- 20. Eisenberger M, Jacobs M. Simultaneous treatment with single-agent chemotherapy and radiation for locally advanced cancer of head and neck. Semin Oncol 1992; 4(Suppl11): 41-6.
- 21. Lee N1, Harris J, Garden AS, Straube W, Glisson B, Xia P, et al. Intensitymodulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol 2009; 27: 3684-90.
- 22. Wolden SL, Chen WC, Pfister DG, Kraus DS, Berry SL, Zelefsky MJ. Intensitymodulated radiation therapy (IMRT) for nasopharyngeal cancer. Update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 2006; 64: 57-62.